文献速递中毒与环境急症呼吸衰竭与机械通气重症综合管理与镇静镇痛

苯基丁酸暴露及其临床效应:一家区域中毒中心的报告

Phenibut exposures and clinical effects reported to a regional poison center.
PubMed 文献 · Am J Emerg Med · 2019-03-09
一句话结论过去五年苯基丁酸暴露呼叫增加,中枢抑制常见,可致呼吸衰竭需气管插管,医生应警惕并准备气道管理。

该研究利用明尼苏达中毒控制系统的电子病历 Toxicall®,回顾性分析了 2000 年 1 月至 2018 年 12 月所有苯基丁酸暴露呼叫。19 年间共 56 次暴露呼叫,其中 48 次(85.7%)发生在过去五年。超过 50% 的患者出现中枢神经系统效应,10.7% 有戒断担忧。48% 的患者因滥用使用,23% 用于治疗焦虑。35.7% 的患者有记录的共同摄入物。无患者因报告的苯基丁酸使用死亡,但 11 例(19.6%)接受了气管插管。结论指出苯基丁酸暴露呼叫增加,中枢抑制常见并伴随需插管的呼吸衰竭等显著临床结局。

要点

  • 19 年间共 56 次苯基丁酸暴露呼叫,其中 48 次(85.7%)发生在过去五年,暴露呼叫呈增加趋势。
  • 超过 50% 的患者出现中枢神经系统效应,10.7% 有戒断担忧。
  • 27 例(48%)因滥用使用苯基丁酸,13 例(23%)用于治疗焦虑。
  • 35.7% 的患者有记录的共同摄入物。
  • 无患者因报告的苯基丁酸使用死亡,但 11 例(19.6%)接受了气管插管。

适用人群与场景

  • 向明尼苏达中毒控制系统报告的苯基丁酸暴露呼叫者,数据来自 Toxicall® 电子病历,时间范围为 2000 年 1 月至 2018 年 12 月。

红旗征与不能漏的情况

  • 苯基丁酸暴露可导致中枢神经系统抑制,并与需气管插管的呼吸衰竭等显著临床结局相关,应准备适当的气道管理。

研究设计与关键结果

  • 研究类型为利用中毒中心电子病历的暴露呼叫分析,样本量为 56 次暴露呼叫,来自明尼苏达中毒控制系统,时间跨度为 2000 年 1 月至 2018 年 12 月。
  • 19 年间共 56 次暴露呼叫,其中 48 次(85.7%)发生在过去五年。
  • 超过 50% 的患者出现中枢神经系统效应,10.7% 有戒断担忧。
  • 27 例(48%)因滥用使用苯基丁酸,13 例(23%)用于治疗焦虑。
  • 35.7% 的患者有记录的共同摄入物。
  • 无患者因报告的苯基丁酸使用死亡,11 例(19.6%)接受了气管插管。

证据类型、等级与局限

  • 证据类型为基于中毒中心电子病历的暴露呼叫分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 医生应意识到苯基丁酸相关的中枢神经系统和呼吸抑制,并准备适当的气道管理。
  • 苯基丁酸易于获得且暴露似乎正在增加,急诊与重症医生在接诊不明原因中枢抑制或呼吸衰竭患者时应考虑苯基丁酸暴露可能。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Phenibut is a synthetically produced central nervous system (CNS) depressant that is structurally similar to the inhibitory neurotransmitter γ-aminobutyric acid (GABA). Phenibut has been identified as a drug of abuse with numerous clinical effects in overdose and a withdrawal syndrome with chronic use. The purpose of this study is to report the incidence of exposure calls regarding phenibut to a poison center, describe the reasons for its use and clinical effects.

METHODS: Study subjects were identified using Toxicall®, the electronic medical record utilized by the Minnesota Poison Control System. All phenibut exposure calls from January 2000 through December 2018 were included. Analysis was performed on incidence of exposure calls, reported reasons for use, signs and symptoms, coingestants, and outcome.

RESULTS: There were 56 exposure calls over 19 years with 48 (85.7%) calls within the past five years. Over 50% of patients had CNS effects and 10.7% had withdrawal concerns. Twenty-seven patients (48%) had abuse as the reason for use and 13 (23%) used phenibut to treat anxiety. There were documented coingestants in 35.7% of patients. No patients died due to reported phenibut use, though 11 patients (19.6%) were intubated.

CONCLUSION: Exposure calls to a regional poison center regarding phenibut have increased over the past five years. CNS depression was common, and associated with significant clinical outcomes including respiratory failure requiring intubation. As phenibut is easily attainable and exposures appear to be increasing, physicians should be aware of phenibut-associated CNS and respiratory depression and be prepared to manage airways appropriately.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. McCabe DJ, Bangh SA, Arens AM, et al. Phenibut exposures and clinical effects reported to a regional poison center. Am J Emerg Med. 2019. PMID: 30878413. doi:10.1016/j.ajem.2019.02.044

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。